This company has been marked as potentially delisted and may not be actively trading. Flex Pharma (FLKS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock FLKS vs. ACET, IMRX, VRCA, IMMX, FBIO, NBRV, MIST, RPTX, MURA, and SPROShould you be buying Flex Pharma stock or one of its competitors? The main competitors of Flex Pharma include Adicet Bio (ACET), Immuneering (IMRX), Verrica Pharmaceuticals (VRCA), Immix Biopharma (IMMX), Fortress Biotech (FBIO), Nabriva Therapeutics (NBRV), Milestone Pharmaceuticals (MIST), Repare Therapeutics (RPTX), Mural Oncology (MURA), and Spero Therapeutics (SPRO). These companies are all part of the "medical" sector. Flex Pharma vs. Adicet Bio Immuneering Verrica Pharmaceuticals Immix Biopharma Fortress Biotech Nabriva Therapeutics Milestone Pharmaceuticals Repare Therapeutics Mural Oncology Spero Therapeutics Adicet Bio (NASDAQ:ACET) and Flex Pharma (NASDAQ:FLKS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership, community ranking and dividends. Which has stronger earnings & valuation, ACET or FLKS? Flex Pharma has lower revenue, but higher earnings than Adicet Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdicet Bio$24.99M1.94-$142.66M-$1.34-0.44Flex Pharma$840K15.76-$21.92MN/AN/A Which has more risk and volatility, ACET or FLKS? Adicet Bio has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500. Comparatively, Flex Pharma has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Do analysts rate ACET or FLKS? Adicet Bio currently has a consensus price target of $7.50, indicating a potential upside of 1,180.30%. Given Adicet Bio's stronger consensus rating and higher probable upside, analysts clearly believe Adicet Bio is more favorable than Flex Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adicet Bio 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Flex Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to ACET or FLKS? In the previous week, Adicet Bio had 2 more articles in the media than Flex Pharma. MarketBeat recorded 2 mentions for Adicet Bio and 0 mentions for Flex Pharma. Adicet Bio's average media sentiment score of 0.93 beat Flex Pharma's score of 0.00 indicating that Adicet Bio is being referred to more favorably in the media. Company Overall Sentiment Adicet Bio Positive Flex Pharma Neutral Is ACET or FLKS more profitable? Adicet Bio has a net margin of 0.00% compared to Flex Pharma's net margin of -1,208.42%. Adicet Bio's return on equity of -53.85% beat Flex Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Adicet BioN/A -53.85% -46.45% Flex Pharma -1,208.42%-98.04%-83.37% Does the MarketBeat Community prefer ACET or FLKS? Flex Pharma received 61 more outperform votes than Adicet Bio when rated by MarketBeat users. Likewise, 73.23% of users gave Flex Pharma an outperform vote while only 58.03% of users gave Adicet Bio an outperform vote. CompanyUnderperformOutperformAdicet BioOutperform Votes30058.03% Underperform Votes21741.97% Flex PharmaOutperform Votes36173.23% Underperform Votes13226.77% Do institutionals and insiders hold more shares of ACET or FLKS? 83.9% of Adicet Bio shares are held by institutional investors. Comparatively, 14.4% of Flex Pharma shares are held by institutional investors. 19.1% of Adicet Bio shares are held by company insiders. Comparatively, 7.6% of Flex Pharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryAdicet Bio beats Flex Pharma on 12 of the 16 factors compared between the two stocks. Get Flex Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FLKS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLKS vs. The Competition Export to ExcelMetricFlex PharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.24M$6.68B$5.44B$7.80BDividend YieldN/A3.17%5.43%4.30%P/E RatioN/A7.1422.1418.40Price / Sales15.76238.89389.70101.29Price / CashN/A65.6738.2034.62Price / Book1.446.266.664.18Net Income-$21.92M$142.48M$3.21B$247.71M Flex Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLKSFlex PharmaN/A$0.73+1.8%N/A+44.2%$13.24M$840,000.000.004ACETAdicet Bio2.294 of 5 stars$0.59+4.2%$7.50+1,171.2%-67.6%$48.79M$24.99M-0.3590IMRXImmuneering3.7681 of 5 stars$1.35+3.5%$12.50+829.4%+1.4%$48.27M$320,000.00-0.6860News CoverageGap UpVRCAVerrica Pharmaceuticals3.3634 of 5 stars$0.52-6.3%$9.50+1,734.0%-92.6%$48.09M$7.57M-0.2940Gap UpIMMXImmix Biopharma2.8457 of 5 stars$1.67+2.4%$7.00+319.4%-11.0%$46.02MN/A-1.959Positive NewsGap UpFBIOFortress Biotech2.6375 of 5 stars$1.56-1.0%$21.00+1,250.5%-4.7%$45.93M$57.68M-0.51170Gap UpNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070MISTMilestone Pharmaceuticals1.659 of 5 stars$0.84+1.0%$17.00+1,923.8%-19.5%$44.82M$1M-1.0430Positive NewsRPTXRepare Therapeutics3.6543 of 5 stars$1.05+13.1%$4.50+328.6%-60.3%$44.64M$53.48M-0.53180Positive NewsHigh Trading VolumeMURAMural Oncology2.4834 of 5 stars$2.56+148.9%$13.00+407.0%-26.3%$43.76MN/A-0.28119High Trading VolumeSPROSpero Therapeutics4.5089 of 5 stars$0.76+8.4%$5.00+557.9%-49.3%$42.49M$27.40M10.86150Positive News Related Companies and Tools Related Companies Adicet Bio Competitors Immuneering Competitors Verrica Pharmaceuticals Competitors Immix Biopharma Competitors Fortress Biotech Competitors Nabriva Therapeutics Competitors Milestone Pharmaceuticals Competitors Repare Therapeutics Competitors Mural Oncology Competitors Spero Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLKS) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flex Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Flex Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FLKS Stock Free FLKS Stock Alerts